These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2824039

  • 1. Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.
    Rozhin J, Robinson D, Stevens MA, Lah TT, Honn KV, Ryan RE, Sloane BF.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6620-8. PubMed ID: 2824039
    [Abstract] [Full Text] [Related]

  • 2. Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors.
    Rozhin J, Gomez AP, Ziegler GH, Nelson KK, Chang YS, Fong D, Onoda JM, Honn KV, Sloane BF.
    Cancer Res; 1990 Oct 01; 50(19):6278-84. PubMed ID: 2400991
    [Abstract] [Full Text] [Related]

  • 3. Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential.
    Sloane BF, Honn KV, Sadler JG, Turner WA, Kimpson JJ, Taylor JD.
    Cancer Res; 1982 Mar 01; 42(3):980-6. PubMed ID: 7059993
    [Abstract] [Full Text] [Related]

  • 4. Cathepsin B: association with plasma membrane in metastatic tumors.
    Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV.
    Proc Natl Acad Sci U S A; 1986 Apr 01; 83(8):2483-7. PubMed ID: 3458210
    [Abstract] [Full Text] [Related]

  • 5. Cathepsin B-like activity in viable tumor cells isolated from rodent tumors.
    Ryan RE, Crissman JD, Honn KV, Sloane BF.
    Cancer Res; 1985 Aug 01; 45(8):3636-41. PubMed ID: 3893687
    [Abstract] [Full Text] [Related]

  • 6. Identification of cell surface cathepsin B-like activity on murine melanomas and fibrosarcomas: modulation by butanol extraction.
    Keren Z, LeGrue SJ.
    Cancer Res; 1988 Mar 15; 48(6):1416-21. PubMed ID: 3345513
    [Abstract] [Full Text] [Related]

  • 7. An intracellular form of cathepsin B contributes to invasiveness in cancer.
    Szpaderska AM, Frankfater A.
    Cancer Res; 2001 Apr 15; 61(8):3493-500. PubMed ID: 11309313
    [Abstract] [Full Text] [Related]

  • 8. The malignant phenotype and cysteine proteinases.
    Sloane BF, Rozhin J, Krepela E, Ziegler G, Sameni M.
    Biomed Biochim Acta; 1991 Apr 15; 50(4-6):549-54. PubMed ID: 1801721
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibition of proteolytic enzymes in an in vivo mouse model for experimental metastasis.
    Ostrowski LE, Ahsan A, Suthar BP, Pagast P, Bain DL, Wong C, Patel A, Schultz RM.
    Cancer Res; 1986 Aug 15; 46(8):4121-8. PubMed ID: 3089587
    [Abstract] [Full Text] [Related]

  • 10. Expression of five cathepsins in murine melanomas of varying metastatic potential and normal tissues.
    Qian F, Bajkowski AS, Steiner DF, Chan SJ, Frankfater A.
    Cancer Res; 1989 Sep 01; 49(17):4870-5. PubMed ID: 2758418
    [Abstract] [Full Text] [Related]

  • 11. The expression of cathepsin B and other lysosomal proteinases in normal tissues and in tumors.
    Qian F, Chan SJ, Gong QM, Bajkowski AS, Steiner DF, Frankfater A.
    Biomed Biochim Acta; 1991 Sep 01; 50(4-6):531-40. PubMed ID: 1801719
    [Abstract] [Full Text] [Related]

  • 12. Characterization of beta-hexosaminidase secretion in rabbit lacrimal gland.
    Andersson SV, Edman MC, Bekmezian A, Holmberg J, Mircheff AK, Gierow JP.
    Exp Eye Res; 2006 Nov 01; 83(5):1081-8. PubMed ID: 16839547
    [Abstract] [Full Text] [Related]

  • 13. Cathepsin B and cystatins: evidence for a role in cancer progression.
    Sloane BF.
    Semin Cancer Biol; 1990 Apr 01; 1(2):137-52. PubMed ID: 2103490
    [Abstract] [Full Text] [Related]

  • 14. Membrane lipids and enzymes of cultured high- and low-metastatic B16 melanoma variants.
    Schroeder F, Gardiner JM.
    Cancer Res; 1984 Aug 01; 44(8):3262-9. PubMed ID: 6146400
    [Abstract] [Full Text] [Related]

  • 15. Isolation of intact lysosomes from human RPE cells and effects of A2-E on the integrity of the lysosomal and other cellular membranes.
    Schütt F, Bergmann M, Holz FG, Kopitz J.
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec 01; 240(12):983-8. PubMed ID: 12483320
    [Abstract] [Full Text] [Related]

  • 16. Diversity of melanoma plasma membrane proteinases: inhibition of collagenolytic and cytolytic activities by minocycline.
    Zucker S, Lysik RM, Ramamurthy NS, Golub LM, Wieman JM, Wilkie DP.
    J Natl Cancer Inst; 1985 Sep 01; 75(3):517-25. PubMed ID: 2993728
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.
    Persky B, Ostrowski LE, Pagast P, Ahsan A, Schultz RM.
    Cancer Res; 1986 Aug 01; 46(8):4129-34. PubMed ID: 3524801
    [Abstract] [Full Text] [Related]

  • 18. The activities and subcellular localization of cathepsin B and cysteine proteinase inhibitors in human ovarian carcinoma.
    Haczyńksa H, Gerber J, Osada J, Warwas M.
    Acta Biochim Pol; 1997 Aug 01; 44(1):113-20. PubMed ID: 9241362
    [Abstract] [Full Text] [Related]

  • 19. Cathepsin B in cells of two rat sarcomas with different rates of spontaneous metastasis.
    Krepela E, Veselý P, Chaloupková A, Zicha D, Urbanec P, Rasnick D, Vicar J.
    Neoplasma; 1989 Aug 01; 36(5):529-40. PubMed ID: 2812149
    [Abstract] [Full Text] [Related]

  • 20. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
    Tournu C, Obled A, Roux MP, Deval C, Ferrara M, Béchet DM.
    Arch Biochem Biophys; 1998 Dec 01; 360(1):15-24. PubMed ID: 9826424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.